Final report of the cosmetic ingredient review expert panel amended safety assessment of calendula officinalis-derived cosmetic ingredients

International Journal of Toxicology

Volumn 29, Issue 6, 2010, Pages

  Andersen, F Alan ^a   Bergfeld, Wilma F ^a   Belsito, Donald V ^a   Hill, Ronald A ^a   Klaassen, Curtis D ^a   Liebler, Daniel C ^a   Marks Jr , James G ^a   Shank, Ronald C ^a   Slaga, Thomas J ^a   Snyder, Paul W ^a  

^a NONE

Author keywords

calendula; cosmetics; safety

Indexed keywords

AMINO ACID; AUROXANTHIN; BETA CAROTENE; CALENDULA OFFICINALIS EXTRACT; CARBOHYDRATE; CAROTENOID; COSMETIC; COUMARIN; FLAVONOID; FLAVOXANTHIN; GAMMA CAROTENE; LIPID; LUTEIN 5,6 EPOXIDE; LUTEOXANTHIN; LYCOPENE; MINERAL; PHENOL; PLANT EXTRACT; QUERCETIN; QUINONE DERIVATIVE; RESIN; RUBIXANTHIN; SESQUITERPENE; STEROID; STEROL; TANNIN; TERPENE; TOCOPHEROL; TRITERPENE; UNCLASSIFIED DRUG; VEGETABLE OIL; CALENDULA EXTRACT; FLOWER EXTRACT;

ACUTE TOXICITY; ANTINEOPLASTIC ACTIVITY; CARCINOGENICITY; CHRONIC TOXICITY; CORIANDER; CYTOTOXICITY; EYE IRRITATION; FLOWER; GENOTOXICITY; HUMAN; IMMUNOSTIMULATION; MARIGOLD; NONHUMAN; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PLANT SEED; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SKIN IRRITATION; SKIN SENSITIZATION; ULTRAVIOLET RADIATION; ACUTE PARENTERAL TOXICITY; AEROSOL; ANALYTIC METHOD; ARTICLE; CALENDULA; CALENDULA OFFICINALIS; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CLINICAL ASSESSMENT; DEVELOPMENTAL TOXICITY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG IMPURITY; DRUG METABOLISM; DRUG SAFETY; EXTRACTION; IMMUNOTHERAPY; MOUTH DISEASE; PHYSICAL CHEMISTRY; SHORT TERM ORAL TOXICITY; SUBCHRONIC TOXICITY; ULTRAVIOLET SPECTROSCOPY; VETERINARY TOXICOLOGY;

ACUTE TOXICITY TESTS; ANIMALS; CALENDULA; CARCINOGENICITY TESTS; CONSUMER PRODUCT SAFETY; COSMETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOWERS; HUMANS; IRRITANTS; MUTAGENICITY TESTS; PHYSICOCHEMICAL PHENOMENA; PLANT EXTRACTS; TOXICITY TESTS, CHRONIC;

ANIMALIA; CALENDULA; CALENDULA OFFICINALIS; CORIANDRUM SATIVUM;

EID: 78650902720     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581810384883     Document Type: Review

References (79)

1. Andersen FA Final report of the safety assessment of calendula officinalis extract and calendula officinalis. Int J Toxicol. 2001 ; 20 (suppl 2). 13-20.
2. Gottschalck TE, Bailey JE, eds. International Cosmetic Ingredient Dictionary and Handbook. Washington D.C: CTFA ; 2008.
3. Fleischner AM Plant extracts: to accelerate healing and reduce inflammation. Cosmet Toilet. 1985 ; 100: 45-58.
4. Budavari S, ed. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. 11th ed. Rahway, NJ: Merck & Co ; 1989: 258.
5. Avramova S., Portarska F., Apostolova B., et al. Source of new products for the cosmetic industry. Med Biol Inf. 1988 ; 4: 28-32.
6. Patri F., Silano V. Calendula officinalis L. Plants in cosmetics. Plants and Plant Preparations Used as Ingredients for Cosmetic Products. Committee of Experts on Cosmetic Products. Strasburg: Council of Europe Publishing ; 2002.
7. D'Amelio FS Sr. Botanicals. A Phytocosmetic Desk Reference. London: CRC Press ; 1999.
8. Calendulae Flos. Escop Monographs. The Scientific Foundation for Herbal Medicinal Products. New York, NY: Thieme; 2003.
9. Kishimoto S., Maoka F., Sumitomo K., Ohmiya A. Analysis of carotenoid composition in petals of calendula (Calendula officinalis L.). Biosci Biotechnol Biochem. 2005 ; 69 (11). 2122-2128.
10. Ctfa. Alban Muller International information on pot marigold. Unpublished data provided by CTFA ; 2006: 11.
11. Ctfa. Crodarom information on tradename Phytexcell Calendula. Unpublished data provided by CTFA ; 2006: 5.
12. Natural Product Consulting. UNITIS-Calendula officinalis. Unpublished data provided by CTFA ; 2006: 45.
13. Eyerman G. Assay of a-Tocopherolquinone in Calendula Officinalis. Unpublished data submitted by the Personal Care Products Council ; 2008: 4.
14. Eyerman G. Assay of Coumarins in Calendula Officinalis. Unpublished data submitted by the Personal Care Products Council ; 2008: 9.
15. Eyerman G. Assay of Catechol in Calendula Officinalis. Unpublished data submitted by the Personal Care Products Council ; 2008: 6.
16. Chemisches Laboratorium Dr. Kurt Richter GmbH. Raw material documentation on Calendula Oil CLR (Calendula Officinalis Extract and soybean (Glycine Soja) oil and tocopherol). Unpublished data provided by CTFA ; 1996.
17. Grau Aromatic GmbH & Co. Specifications of Calendula Extract HS 2380 G(Calendula Officinalis Extract and propylene glycol). Unpublished data provided by CTFA ; 1998: 1.
18. Ichimaru Pharcos Co, Ltd. Specifications of Toukinsenda Liquid (Calendula Officinalis Extract and butylene glycol and water). Unpublished data provided by CTFA ; 1994: 5.
19. Vidal-Ollivier E., Elias R., Crespin F., Diaz-Lanza AM, Maillard C., Balansard G. Dosage par C.L.H.P. des flavonoïdes majoritaires de Calendula officinalis L. en fonction de la variété culturale et de lat date de récolte. Pharm Acta Helv. 1991 ; 66: 318-320.
20. Pietta P., Bruno A., Mauri P., Fava A. Separation of flavanol-2- Oglycosides from Calendula officinalis and Sambucus nigra by high-performance liquid and micellar electrokinetic capillary chromatography. J Chromatogr. 1992 ; 593: 165-170.
21. Gracza L. Oxygen-containing terpene derivatives from Calendula officinalis. Planta Med. 1987 ; 53 (2). 227.
22. Ctfa. UV Absorption Spectra for Calendula Officinalis Oil and Extracts. Unpublished data provided by CTFA ; 2006: 12.
23. FDA. Cosmetic ingredient use as a function of product category. VCRP - FDA Database. Silver Spring, MD: US Food and Drug Administration ; 2006.
24. Ctfa. Concentration of use data on Calendula Officinalis Flower Extract and Calendula Officinalis Flower Oil. Unpublished data provided by CTFA ; 2005: 2.
25. European Commission.Search of the European Commission's website for ''calendula.''. http://ec.europa.eu/health/ph-risk/committees/04-sccp/04-sccp- en.htm
26. Ministry of Health, Labor and Welfare (MHLW). MHW Ordinance No. 332. Ingredients of quasi-drugs. Products to be used directly on the body. 9-1- 2000. 2-2, 1 -chone, Kasumigaseki, Chiyoda-ku, Tokyo, 100-8045, Japan: Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division.
27. Mhlw. MHW Ordinance No. 331, Appendix 1. List of ingredients that cosmetics shall not contain. 2-2, 1 -chone, Kasumigaseki, Chiyoda-ku, Tokyo, 100-8045, Japan: Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division ; 3-1- 2005.
28. Willeke K., Baron, PA Industrial Hygiene. Aerosol Measurement. Principles Techniques and Applications. New York, NY: John Wiley and Sons Inc ; 1993.
29. Absorption of Toxicants by the Lungs. In: Klassen CD, ed. Casarret and Doull's Toxicology: The Basic Science of Poisons. New York, NY: McGraw-Hill ; 2008.
30. Bower D. Unpublished information on hair spray particle sizes provided at CIR Expert Panel Meeting ; 1999.
31. Johnsen MA The influence of particle size. Spray Technol Market. 2004 ; 11: 24-27.
32. Food and Drug Administration (FDA). 1997. Spices and other natural seasonings and flavorings. Code of Federal Regulations. Title 21 §182.10.
33. Wagner VH, Proksch A., Reiss-Maurer I., et al. Immunostimulating polysaccharides (heteroglycans) from higher plants. Arzenheimittelforschung. 1985 ; 35 (7). 1069-1075.
34. Cosmetic, Toiletry, and Fragrance Association (CTFA). Acute oral toxicity of Calendula Officinalis Extract. Unpublished data provided by CTFA ; 1980.
35. Silva EJR, Gonçalves ES, Aguiar FJS, et al. Toxicological studies on hydroalcohol extract of Calendula officinalis L. Phytother Res. 2007 ; 21 (4). 332-336.
36. Harikumar KB, Nimita CV, Preethi KC, Kuttan R. Toxicity profile of lutein and lutein ester isolated from marigold flowers (Tagetes erecta). Int J Toxicol. 2008 ; 27 (1). 1-9.
37. Dhar ML, Shar MM, Dhawan BN, Mehrotra BN, Ray C. Screening of Indian plants for biological activity: Part I. Indian J Exp Biol. 1968 ; 6 (4). 232-247.
38. Hindle VA, Mathijsen-Kamman AA, Stockhofe N., Cone JW The performance of young pigs fed different amounts of marigold (Calendula officinalis) meal; a pilot study. Netherlands J Agric Sci. 2002 ; 50: 83-94.
39. Silva EJR, Aguiar FJS, Gonçalves ES, et al. Evaluation of subchronic treatment with the hydroalcoholic extract of Calendula offininalis L. on biochemical and hematological parameters in female Wistar rats. Braz J Pharmacogn. 2005 ; 15 (2). 88-93.
40. Ctfa. Skin and ocular irritation studies on 10% Calendula Officinalis Extract. Unpublished data provided by CTFA ; 1983: 2.
41. Ctfa. Dermal and ocular irritation studies and a human patch test on eye products containing 1.0% Calendula Officinalis Extract. Unpublished data provided by CTFA ; 1986. 4.
42. Biolab SGS. Acute eye irritation, primary skin irriation, and skin sensitization studies of Calendula Dry Eztract Lav. and acute eye irritation and primary skin irriation tests of Calendola Estratto Glicolico using rabbits. Unpublished data provided by CTFA ; 1993: 12.
43. Biolab. Acute eye irritation and primary skin irriation studies of Phytelene Calendula (Calendula Officinalis Flower Extract) in rabbits. Unpublished data provided by CTFA ; 1997: 6.
44. Ctfa. Modified Magnusson-Kligman guinea pig maximization test for contact sensitization of Calendula Officinalis Extract. Study project GPA-01-84. Final Report May 14. Unpublished data provided by CTFA ; 1984.
45. Bickers DR, Calow P., Greim HA, et al. The safety assessment of fragrance materials. Regul Toxicol Pharmacol. 2003 ; 32 (2). 218-273.
46. Elias R., DeMeo M., Vidal-Ollivier E., Laget M., Balansard G., Dumenil G. Antimutagenic activity of some saponins isolated from Calendula officinalis L., C. Arvensis L., and Hedera helix L. Mutagenesis. 1990 ; 5 (4). 327-331.
47. Graf U., Alonzo Moraga A., Castro R., Diaz Carillo E. Genotoxicity testing of different types of beverages in the Drosophila wing somatic mutation and recombination test. Food Chem Toxicol. 1994 ; 32 (5). 423-430.
48. Ramos A., Edreira A., Vizoso A., Betancourt J., López M., Décalo M. Genotoxicity of an extract of Calendula officinalis L. J Ethnopharmacol. 1998 ; 61 (1). 49-55.
49. International Agency for Research on Cancer (IARC). IARC Monographs on the evaluation of carcinogenic risks to humans. Vol 77. IARC: Lyon, France; 2000.
50. Hard GC, Seely JC, Betz LJ, Hayashi S. Re-evaluation of the kidney tumors and renal histopathology occurring in a 2-year rat carcinogenicity bioassay of quercitin. Food Chem Toxicol. 2007 ; 45 (4). 600-608.
51. Hilltop Research. Report of a human skin test of cumulative irritation on formula #38425-08 containing 1.0% Calendula Extract (RI3459). Study 86-0652-74 dated July 11. Unpublished data provided by CTFA ; 1986: 15.
52. Ctfa. Four-day mini-cumulative irritancy assay of an eye product containing 1% Calendula Officinalis Extract. Unpublished data provided by CTFA ; 1990: 1.
53. Derma Consult GmbH. Examination of O/W cream at 100% and 10% by human patch test. Unpublished data provided by CTFA ; 2005: 12.
54. Rodriquez E., Mitchell JC Absence of contact hypersensitivity to some perfume materials derived from Compositae species. Contact Dermatitis. 1977 ; 3 (3). 168-169.
55. Ctfa. Allergic contact sensitization test on eyecream 38425-12 containing 1.0% Calendula Officinalis Extract (RI3459). Unpublished data provided by CTFA ; 1986.
56. TKL Research. Repeated insult patch test of product #38425-22 containing 1.0% Calendula Extract (RI3459). Unpublished data provided by CTFA ; 1987: 11.
57. de Groot AC, Bruynzeel DP, Bos JD, et al. The allergens in cosmetics. Arch Dermatol. 1988 ; 124 (10). 1525-1529.
58. Bruynzeel D., van Ketel WG, Young E., Van Roost T., Smeenk G. Contact sensitization by alternative topical medicaments containing plant extracts. Contact Dermatitis. 1992 ; 27 (4). 278-279.
59. Wrangsjö K., Ros AM, Wahlberg JE Contact allergy to Compositae plants in patients with summer-exacerbated dermatitis. Contact Dermatitis. 1990 ; 22 (3). 148-154.
60. Paulsen E., Andersen KE, Hausen BM Compositae dermatitis in a Danish dermatology department in one year. Contact Dermatitis. 1993 ; 29 (1). 6-10.
61. Final report of the amended safety assessment of pyrocatechol. Int J Toxicol. 1997 ; 16 (suppl 1). 11-58.
62. Final report on the safety assessment of oleic acid, lauric acid, palmitic acid, myristic acid, and stearic acid. J Am Coll Toxicol. 1987 ; 6: 321-401.
63. Annual review of cosmetic ingredient safety assessments-2004/ 2005-oleic, lauric, palmitic, myristic and steraic acids. Int J Toxicol. 2006 ; 25 (suppl 2). 41-47.
64. Final report on the safety assessment of fossil and synthetic waxes. J Am Coll Toxicol. 1984 ; 3 (3). 43-99.
65. Final report on the safety assessment of t-Butyl Hydroquinone. J Am Coll Toxicol. 1991 ; 10 (1). 7.
66. Final report of the safety assessment of salicylic acid, butyloctyl salicylate, calcium salicylate, C12-15 alkyl salicylate, capryloyl salicylic acid, hexyldodecyl salicylate, isocetyl salicylate, isodecyl salicylate, magnesium salicylate, MEA-salicylate, ethylhexyl salicylate, potassium salicylate, methyl salicylate, myristyl salicylate, sodium salicylate, TEA-salicylate, and tridecyl salicylate. Int J Toxicol. 2003 ; 22 (suppl 3). 1-108.
67. Final report of the safety assessment of tocopherol, tocopersolan, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/ oleate, tocopheryl nicotinate, tocopheryl succinate, dioleyl tocopheryl methylsilanol, and potassium ascorbyl tocopheryl phosphate. Int J Toxicol. 2002 ; 21 (suppl 1). 51-116.
68. Final report of the amended safety assessment of PEG-5,-10,-16, -25,-30, and-40 Soy Sterol. Int J Toxicol. 2004 ; 23 (suppl 2). 23-47.
69. Annual review of cosmetic ingredient safety assessments-2004/ 2005-Cholesterol. Int J Toxicol. 2006 ; 25 (suppl 2). 21-22.
70. Final report on the safety assessment of cholesterol. J Am Coll Toxicol. 1986: 5491-516.
71. Cosmetic Ingredient Review Expert Panel. Annual review of cosmetic ingredient safety assessments-2002/2003. Int J Toxicol. 2005 ; 24 (suppl 1). 1-102.
72. Final report on the safety assessment of Pyrogallol. J Am Coll Toxicol. 1991 ; 10 (1). 67-85.
73. Quercetin. Plants in cosmetics-potentially harmful components. Strasbourg: Council of Europe ; 2006.
74. Harwood M., Danielewska-Nikiel B., Borzelleca JF, Flamm GW, Williams GM, Lines TC A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 2007 ; 45 (11). 2179-2205.
75. Kitamura Y., Nishikawa A., Nakamura H., et al. Effects of N-acetylcycteine, quercetin, and phytic acid on spontaneous hepatic and renal lesions in LEC rats. Toxicol Pathol. 2005 ; 33 (5). 584-592.
76. International Agency for Research on Cancer (IARC). IARC Monographs on the evaluation of carcinogenic risks to humans. Vol 56. Lyon, France: IARC ; 1993.
77. Re TA, Mooney D., Antignac E., et al. Application of the Threshold of Toxicologic Concern Approach for the Safety Evaluation of Calendula (Calendula officinalis) Petals and Extracts Used in Cosmetic and Personal Care Products. Unpublished data submitted by the Personal Care Products Council ; 2008: 35.
78. Toxtree [ computer program ]. 2008. Sofia, Bulgaria: Ideaconsult Ltd. http://ecb.jrc.ec.europa.eu/qsar/qsar-tools/index.php?c=TOXTREE
79. European Medicines Agency. Committee on Herbal Medicinal Products (HMPC). Assessment Report for the Cevelopment of Community Monographs and for Inclusion of Herbal Substance(s), Preparation(s) or Combinations Thereof in the Community List. 2008. http://www.emea.europa.eu/pdfs/human/hmpc/calendula-officinalis- flos/17928207en.pdf.ReportNo.EMEA/HMPC/179282/2007.